Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
AbbVie Community
NYSE:ABBV Community
1
Narratives
written by author
0
Comments
on narratives written by author
469
Fair Values set
on narratives written by author
Community Investing Ideas
AbbVie
Popular
Undervalued
Overvalued
AbbVie
AN
AnalystConsensusTarget
Consensus Narrative from 26 Analysts
Expanding Immunology And Neuroscience Will Reshape Global Healthcare
Key Takeaways Strong performance in immunology and neuroscience, supported by new product launches and expanding indications, helps offset losses from older drugs facing competition. Strategic pipeline development, international growth, and operational efficiency position the company to sustain profitability and adapt to evolving industry trends.
View narrative
US$214.77
FV
4.7% undervalued
intrinsic discount
7.73%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
239
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
ABBV
ABBV
AbbVie
Your Fair Value
US$
Current Price
US$204.68
0.7% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
81b
2015
2018
2021
2024
2025
2027
2030
Revenue US$81.1b
Earnings US$5.2b
Advanced
Set Fair Value